University of Reading
Reading, RG6 6DZ, United Kingdom
NCT Number: NCT07006909
Cancer is a major health challenge, and early detection is crucial for improving patient outcomes. Research has shown that cancer can alter the way the body processes nutrients. This study aims to explore whether these metabolic changes can be detected through a simple, non-invasive method: analysing hair. Hair grows slowly over time, potentially capturing subtle metabolic changes that occur during cancer development. By studying the nitrogen stable isotope composition in hair samples donated by individuals diagnosed with cancer, we aim to identify potential early markers of the disease. Participants will be asked to donate a small strand of hair, which will be analysed using a laboratory technique called Isotope Ratio Mass Spectrometry (IRMS). The findings from this study could contribute to new, non-invasive screening tools for early cancer detection.
Trial opening soon.
Get NotifiedHealthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Cancer diagnosis, sufficient hair
Exclusion criteria
-
Time frame: Approximately one year
Longitudinal changes in d15N in hair samples to obtain a time-series
Contact information is provided by the study sponsor or research team.
University of Reading
Other
Acronym: HI-CARE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07739563
Behavior, Breast Cancer
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT07739849
Cancer, Hemic and Lymphatic Diseases
View Trial DetailsNCT07735442
Cancer, Neoplasms
Boston, Massachusetts, United States
View Trial DetailsNCT07731425
Cancer, Neoplasms
Boston, Massachusetts, United States
View Trial Details